Strategies for the Development of Glycomimetic Drug Candidates
Molecular Pharmacy, Dept. Pharmaceutical Sciences, University of Basel, Klingelbergstr. 50, 4056 Basel, Switzerland
Pharmaceuticals 2019, 12(2), 55; https://doi.org/10.3390/ph12020055
Received: 15 March 2019 / Revised: 3 April 2019 / Accepted: 9 April 2019 / Published: 11 April 2019
(This article belongs to the Special Issue Carbohydrates 2018)
Carbohydrates are a structurally-diverse group of natural products which play an important role in numerous biological processes, including immune regulation, infection, and cancer metastasis. Many diseases have been correlated with changes in the composition of cell-surface glycans, highlighting their potential as a therapeutic target. Unfortunately, native carbohydrates suffer from inherently weak binding affinities and poor pharmacokinetic properties. To enhance their usefulness as drug candidates, ‘glycomimetics’ have been developed: more drug-like compounds which mimic the structure and function of native carbohydrates. Approaches to improve binding affinities (e.g., deoxygenation, pre-organization) and pharmacokinetic properties (e.g., limiting metabolic degradation, improving permeability) have been highlighted in this review, accompanied by relevant examples. By utilizing these strategies, high-affinity ligands with optimized properties can be rationally designed and used to address therapies for novel carbohydrate-binding targets.
View Full-Text
Keywords:
carbohydrate; glycomimetic; drug development; lectin; lead optimization; binding affinity
▼
Show Figures
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Hevey, R. Strategies for the Development of Glycomimetic Drug Candidates. Pharmaceuticals 2019, 12, 55. https://doi.org/10.3390/ph12020055
AMA Style
Hevey R. Strategies for the Development of Glycomimetic Drug Candidates. Pharmaceuticals. 2019; 12(2):55. https://doi.org/10.3390/ph12020055
Chicago/Turabian StyleHevey, Rachel. 2019. "Strategies for the Development of Glycomimetic Drug Candidates" Pharmaceuticals 12, no. 2: 55. https://doi.org/10.3390/ph12020055
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Search more from Scilit